Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide

Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide

Dave Singh,1 Massimo Corradi,2 Monica Spinola,3 Alberto Papi,4 Omar S Usmani,5 Mario Scuri,3 Stefano Petruzzelli,3 Jørgen Vestbo1 1Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, UK; 2Department of Medicine and Surgery, University of Parma,...

Full description

Bibliographic Details
Main Authors: Singh D, Corradi M, Spinola M, Papi A, Usmani OS, Scuri M, Petruzzelli S, Vestbo J
Format: Article
Language:English
Published: Dove Medical Press 2017-10-01
Series:International Journal of COPD
Subjects:
COPD
inhaled triple therapy
Beclomethasone Diproprionate
Formoterol Fumarate and Glycopyrronium Bromide.
Online Access:https://www.dovepress.com/triple-therapy-in-copd-new-evidence-with-the-extrafine-fixed-combinati-peer-reviewed-article-COPD

Internet

https://www.dovepress.com/triple-therapy-in-copd-new-evidence-with-the-extrafine-fixed-combinati-peer-reviewed-article-COPD

Similar Items